Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and irl 1620

angiotensin ii has been researched along with irl 1620 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Claing, A; D'Orléans-Juste, P; Télémaque, S; Warner, TD; Yano, M1
Claing, A; D'Orléans-Juste, P; Gratton, JP; Télémaque, S1
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N1

Other Studies

3 other study(ies) available for angiotensin ii and irl 1620

ArticleYear
Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat.
    British journal of pharmacology, 1993, Volume: 110, Issue:2

    Topics: Amino Acid Sequence; Angiotensin II; Animals; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; In Vitro Techniques; Male; Mesenteric Arteries; Mesenteric Veins; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Norepinephrine; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Endothelin; Vasoconstriction; Vasodilation

1993
Endothelin-1 induces vasoconstriction and prostacyclin release via the activation of endothelin ETA receptors in the perfused rabbit kidney.
    European journal of pharmacology, 1993, Jun-24, Volume: 237, Issue:2-3

    Topics: Angiotensin II; Animals; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Epoprostenol; Female; In Vitro Techniques; Kidney; Male; Peptide Fragments; Peptides, Cyclic; Perfusion; Rabbits; Receptor, Endothelin A; Receptors, Endothelin; Vasoconstriction

1993
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation

2009